VERTEX PHARMACEUTICALS INC / MA Quarterly Operating Lease, Liability in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly Operating Lease, Liability history and growth rate from Q1 2019 to Q3 2024.
  • Vertex Pharmaceuticals Inc / Ma Operating Lease, Liability for the quarter ending September 30, 2024 was $1.66B.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.66B Sep 30, 2024 10-Q 2024-11-05
Q4 2023 $382M -$46.4M -10.8% Dec 31, 2023 10-Q 2024-11-05
Q4 2022 $428M +$17.4M +4.24% Dec 31, 2022 10-K 2024-02-15
Q4 2021 $411M +$49.7M +13.8% Dec 31, 2021 10-K 2023-02-10
Q4 2020 $361M +$265M +277% Dec 31, 2020 10-K 2022-02-09
Q3 2020 $269M +$197M +277% Sep 30, 2020 10-Q 2020-10-30
Q4 2019 $95.8M Dec 31, 2019 10-K 2021-02-11
Q3 2019 $71.2M Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $68.4M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $71M Mar 31, 2019 10-Q 2019-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.